Position in IMCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,687,572
-$2,549,437 QoQ
Shares Held
116,144
-43.9% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 136 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,049,375,424 across 337 Biotechnology names. IMCR ranks #157 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in IMCR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,687,572 | 116,144 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,237,009 | 206,866 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $8,147,719 | 234,737 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,695,599 | 211,825 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $6,062,613 | 193,200 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,764,752 | 295,408 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,592,520 | 189,577 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,870,148 | 284,939 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,953,385 | 175,668 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $13,256,685 | 203,949 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $10,731,840 | 157,082 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,547,806 | 126,162 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,841,242 | 97,419 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $28,822 | 583 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $33,157 | 581 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $55,060 | 1,173 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $104,953 | 2,813 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $204,276 | 6,832 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $121,825 | 3,558 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $83,518 | 2,253 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,662 | 145 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $4,257 | 100 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||